The investment seeks capital appreciation through long-term investments primarily in securities of mid-sized companies with undervalued assets or favorable growth prospects... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GMRIX | 13.70 | 0.04 | +0.29% |
| Nationwide Small Cap Index R6 | |||
| NQQQX | 46.26 | 0.11 | +0.24% |
| Shelton Nasdaq-100 Index Institutional | |||
| DVMFX | 34.70 | 0.07 | +0.20% |
| Invesco Developing Markets R5 | |||
| HCPIX | 114.02 | N/A | N/A |
| ProFunds UltraSector Health Care Inv | |||
| MIOIX | 32.38 | -0.03 | -0.09% |
| Morgan Stanley Inst International Opp I | |||
A.I.dvisor indicates that over the last year, BARUX has been closely correlated with FSMAX. These tickers have moved in lockstep 95% of the time. This A.I.-generated data suggests there is a high statistical probability that if BARUX jumps, then FSMAX could also see price increases.
| Ticker / NAME | Correlation To BARUX | 1D Price Change % | ||
|---|---|---|---|---|
| BARUX | 100% | +0.04% | ||
| FSMAX - BARUX | 95% Closely correlated | +0.20% | ||
| JDMAX - BARUX | 85% Closely correlated | +0.09% | ||
| JDMRX - BARUX | 85% Closely correlated | +0.08% | ||
| RPTIX - BARUX | 76% Closely correlated | +0.15% | ||
| RPMGX - BARUX | 76% Closely correlated | +0.15% | ||
More | ||||